Correlation Between Scpharmaceuticals and ATyr Pharma
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and ATyr Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and ATyr Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and ATyr Pharma, you can compare the effects of market volatilities on Scpharmaceuticals and ATyr Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of ATyr Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and ATyr Pharma.
Diversification Opportunities for Scpharmaceuticals and ATyr Pharma
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Scpharmaceuticals and ATyr is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and ATyr Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATyr Pharma and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with ATyr Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATyr Pharma has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and ATyr Pharma go up and down completely randomly.
Pair Corralation between Scpharmaceuticals and ATyr Pharma
If you would invest (100.00) in ATyr Pharma on August 28, 2024 and sell it today you would earn a total of 100.00 from holding ATyr Pharma or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 0.0% |
| Values | Daily Returns |
Scpharmaceuticals vs. ATyr Pharma
Performance |
| Timeline |
| Scpharmaceuticals |
| ATyr Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Scpharmaceuticals and ATyr Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scpharmaceuticals and ATyr Pharma
The main advantage of trading using opposite Scpharmaceuticals and ATyr Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, ATyr Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATyr Pharma will offset losses from the drop in ATyr Pharma's long position.| Scpharmaceuticals vs. Capricor Therapeutics | Scpharmaceuticals vs. Soleno Therapeutics | Scpharmaceuticals vs. Bio Path Holdings | Scpharmaceuticals vs. Moleculin Biotech |
| ATyr Pharma vs. Mereo BioPharma Group | ATyr Pharma vs. Terns Pharmaceuticals | ATyr Pharma vs. PDS Biotechnology Corp | ATyr Pharma vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |